U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778407) titled 'TDXD in Metastatic HER2-Positive Breast Cancer' on Aug. 17. Brief Summary: A single-center... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778524) titled 'Alpelisib Challenge Test (ACT)' on Aug. 18. Brief Summary: The goal of this study is to te... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780500) titled 'REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension' o... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779057) titled 'Comparison of High- Versus Low-Dose Aspirin for Pregnancy Outcomes in Women at High Risk of... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779551) titled 'Comparison of Two Drugs Bupivacaine and Ropivacaine for Postoperative Analgesia in Bilatera... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779616) titled 'Study of PTC844 in Participants With Active Rheumatoid Arthritis' on Aug. 18. Brief Summar... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator’s Choice of Chemotherapy... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmac... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Ef... Read More